Across the entire cohort, intratumoral immune cell densities in lymph node metastases were higher than in bone metastases (CD3+, CD8+, FoxP3+ and CD20+ cells) or tumors located in the urinary tract (CD3+, FoxP3+ and CD20+ cells). This evidence concerns the gene FOXP3 and metastatic malignant neoplasm in the lymph nodes.